Levels of insulin and glucagon at either sampling site (Figure 2, O and P) were unaltered
Microdosing was not part of those studies
Weight loss, achieved through a combination of diet, exercise, and lifestyle changes, can help improve GLP-1 levels and insulin sensitivity
Key findings from the #REDEFINE 1 program of investigational drug CagriSema in #overweight/obesity, including #cardiovascular risk reduction, body composition, and target-achievement analyses
And the full body composition effects, the kind you can see in the mirror, usually require 3 to 6 months of consistent use
This makes it part of a rising class of compounds that support longevity-focused research, metabolic mapping, and non-invasive modeling - all while remaining outside the consumer market entirely